Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery

Disease progression prediction and therapeutic drug target discovery for Coronavirus disease 2019 (COVID-19) are particularly important, as there is still no effective strategy for severe COVID-19 patient treatment. Herein, we performed multi-platform omics analysis of serial plasma and urine sample...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Signal Transduct Target Ther
Main Authors: Li, Yuming, Hou, Guixue, Zhou, Haibo, Wang, Yanqun, Tun, Hein Min, Zhu, Airu, Zhao, Jingxian, Xiao, Fei, Lin, Shanwen, Liu, Dongdong, Zhou, Dunrong, Mai, Lang, Zhang, Lu, Zhang, Zhaoyong, Kuang, Lijun, Guan, Jiao, Chen, Qiushi, Wen, Liyan, Zhang, Yanjun, Zhuo, Jianfen, Li, Fang, Zhuang, Zhen, Chen, Zhao, Luo, Ling, Liu, Donglan, Chen, Chunke, Gan, Mian, Zhong, Nanshan, Zhao, Jincun, Ren, Yan, Xu, Yonghao
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group UK 2021
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8047575/
https://ncbi.nlm.nih.gov/pubmed/33859163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41392-021-00508-4
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares